GGrantIndex
Sort

23,748 grants matching melanoma

Cancer and Leukemia Group B

$1,710,507
Richard L Schilsky · University Of Chicago · U10 · FY2009 · CA

Studies of Populations Exposed to Environmental Sources of Radiation

$1,710,227
Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Consequences of chronic Interferon-gamma expression on the host

$1,703,781
Howard Young · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Consultation and Collaboration

$1,701,384
Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

Moffitt Skin Cancer SPORE

$1,699,611
Vernon K. Sondak · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2015 · CA

Animal Model and Genotyping Core Support Facility

$1,698,097
Wendy Du Bois · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Award of Task Order 3 entitled "A Dual AKT/PDPK1 Inhibitor for Actinic Keratosis and Skin Cancer Prevention in Immunocompromised Individuals"

$1,697,599
Alexander Lyubimov · University Of Illinois At Chicago · N01 · FY2018 · CA

PROTON RADIATION THERAPY RESEARCH

$1,692,753
Thomas F Delaney · Massachusetts General Hospital · P01 · FY2008 · CA

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

$1,692,241
William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2023 · CA

Repository Services for epidemiology studies

$1,692,154
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

Overcoming BRAF-inhibitor Resistance in Melanoma

$1,688,850
Antoni Ribas · University Of California Los Angeles · P01 · FY2015 · CA

Overcoming BRAF-inhibitor Resistance in Melanoma

$1,688,850
Antoni Ribas · University Of California Los Angeles · P01 · FY2017 · CA

Overcoming BRAF-inhibitor Resistance in Melanoma

$1,688,850
Antoni Ribas · University Of California Los Angeles · P01 · FY2016 · CA

Imaging mechanisms of metastatic tumor formation in situ

$1,688,533
Gaudenz Danuser · Ut Southwestern Medical Center · U54 · FY2021 · CA

POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA

$1,688,420
John Wayne Cancer Institute · R01 · FY2000 · CA

NYULH Metastasis Research Network Center (NYULH MetNet Center)

$1,688,223
Eva Hernando · New York University School Of Medicine · U54 · FY2022 · CA

ER Stress and Mitochondrial Biogenesis in Melanoma

$1,687,873
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2017 · CA

ER Stress and Mitochondrial Biogenesis in Melanoma

$1,687,873
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2018 · CA

ER Stress and Mitochondrial Biogenesis in Melanoma

$1,687,873
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2020 · CA

Consequences of chronic Interferon-gamma expression on the host

$1,685,529
Howard Young · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

BIOLOGY OF ONCOGENES AND TUMOR SUPPRESSOR GENES

$1,685,077
Massachusetts Institute Of Technology · P01 · FY2005 · CA

Structural and functional characterization of T and NK cell receptors

$1,683,228
Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Multicenter Selective Lymphadenectomy Trial (MSLT II) in Melanoma

$1,682,114
Mark B Faries · Saint John'S Cancer Institute · R01 · FY2016 · CA

Moffitt Skin Cancer SPORE

$1,681,719
Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2014 · CA

Moffitt Skin Cancer SPORE

$1,681,718
Vernon K. Sondak · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2016 · CA